Real-time enrollment status for this central line associated blood stream infections (clabsi) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:48 AM UTC
| NCT Number | NCT07108660 |
| Recruiting Status | Recruiting |
| Condition | Central Line Associated Blood Stream Infections (CLABSI) |
| Phase | Clinical Trial |
| Target Enrollment | 17,800 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Swedish Medical Center |
| Last Updated on CT.gov | August 15, 2025 (Aug 15, 2025) |
As of July 13, 2026: Clinical trial NCT07108660 is currently recruiting participants. This clinical trial study for central line associated blood stream infections (clabsi) is actively seeking new participants at 19 locations across the United States. The study is sponsored by Swedish Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07108660 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07108660 was last updated Aug 15, 2025 (August 15, 2025). HelloStudys verifies this status automatically.